Table 5.

SM: multivariate analyses of prognostic factors for PFS and OS for the entire patient series (n = 34)

Disease featuresnPFSOS
HR (95% CI)PHR (95% CI)P
Clinical and laboratory features
 Hemoglobin, g/L
  <1005NTNS
  ≥10029
 Skin lesions
  No10NTNS
  Yes24
 Platelets, ×109/L
  <10011NSNS
  ≥10023
 β2-microglobulin, µg/mL
  <2.57NTNS
  ≥2.520
 SAP, U/L
  <15016NSNS
  ≥15014
 Splenomegaly
  No11NSNS
  Yes23
Gene panel mutational status
S/A/R
  WT23NSNS
  Mutated11
S/A/R/E
  WT197.6 (2.2-2.6).00113.1 (2.7-64).001
  Mutated15
  • NS, not statistically significant (P > 0.05); NT, not tested.